Potential cost-effectiveness of community availability of tenofovir, lamivudine, and dolutegravir for HIV prevention and treatment in east, central, southern, and west Africa: a modelling analysis.
Lancet Glob Health
; 11(10): e1648-e1657, 2023 10.
Article
in En
| MEDLINE
| ID: mdl-37734807
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
/
2_ODS3
/
4_TD
Database:
MEDLINE
Main subject:
HIV Infections
/
Lamivudine
Type of study:
Health_economic_evaluation
/
Prognostic_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Female
/
Humans
/
Male
Country/Region as subject:
Africa
Language:
En
Journal:
Lancet Glob Health
Year:
2023
Document type:
Article